Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2007-08-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Those with a cervical spinal cord injury
No interventions assigned to this group
2
Those with a thoracic spinal cord injury
No interventions assigned to this group
3
Healthy, control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Must have a C1-C8 or T7-T12/L1 lesion.
3. Must be ASIA Impairment Scale grade A or B.
4. Must not require the use of a ventilator.
5. Must not have type I or II diabetes.
6. Must not have any current pressure sores.
7. Must be cognitively competent and have no concomitant brain damage.
8. The study physician will determine for each subject whether any medications will preclude her/him from study participation. Any subject taking anti-cholinergic medication will be asked to not take that medication after midnight prior to study day 2 (they can take it following the hypoglycemia challenge on study day 2).
Exclusion Criteria
2. Neonates.
3. Pregnant women; a negative pregnancy test will be required for all potential female subjects in reproductive years.
4. Prisoners.
5. Cognitively impaired adults.
6. Institutionalized individuals.
7. Children under age 18.
8. Non-English speaking individuals.
9. Anyone taking lipid altering medication.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of California, Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Irvine
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006-5395
Identifier Type: -
Identifier Source: org_study_id